News

The ALLG, with the support of its Consumer Representative Panel, several clinician co-authors and numerous cancer organisations including the Cancer Council of Australia, Cancer Society of New [...]

A group of senior specialist physicians from Australia and New Zealand – including ALLG Member haematologists as well as oncologists and infectious disease physicians – have published new [...]

The ALLG is continuing to monitor the coronavirus (COVID-19) situation closely.

Sunday, March 8, is International Women’s Day. To mark the occasion, the ALLG is highlighting its continuing focus on gender diversity in haematology and clinical trials. We believe in [...]

The Australasian Leukaemia & Lymphoma Group (ALLG) warmly welcomes Ms Lisa Keenan to the ALLG Board of Directors.

We are pleased to announce that Prof Harry Iland, AM MBBS FRACP FRCPA MHGSA, has been awarded Life Membership with the Australasian Leukaemia & Lymphoma Group (ALLG).

We are pleased to announce that A/Prof Max Wolf, MBBS FRACP FRCPA, was awarded Life Membership with the Australasian Leukaemia & Lymphoma Group (ALLG) at the November 2019 ALLG Scientific Meeting [...]

Associate Professor Jake Shortt from Monash Health has been appointed the new Deputy Chair of ALLG Scientific Advisory Committee (SAC).

The ALLG is pleased to announce the applications for the 2020 Scholarships & Awards Program opened on February 10th. Two scholarships are available – the Anne Lenton Memorial Scholarship ($5,000) [...]

Australia's Minister for Health, the Hon. Greg Hunt MP, announced today that access to the CAR T-cell therapy, tisagenlecleucel, will be expanded to include those battling particular types of [...]

At the ALLG, we love to highlight our members' good works to help those affected by blood cancer.

Conferences are a key meeting place for the ALLG and its members to keep up-to-date with the latest developments in blood cancers and to facilitate collaborations with international research [...]